Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 478

Positioning a portfolio for today's market conditions

Brad Kinkelaar is Senior Managing Director and Lead Portfolio Manager for the Barrow Hanley Global Share Fund. Barrow Hanley Global Investors was founded in 1979 in Dallas, USA, and is now part of Perpetual Asset Management International.

Q: In the last two years, your Global Share Fund is well ahead of its benchmark. What have been the big calls and what are the major themes for the future?

BK: Value stocks have seen a resurgence in outperformance this year-to-date on the back of multiple compressions in the higher growth areas of the market, and it’s important for managers to perform in line with their style as part of a client’s broader asset allocation.

We would not attribute this performance to ‘big calls,’ as our process looks to find dislocations in the market through a bottom-up, fundamental process. Our holdings in the Industrials and Consumer Discretionary sectors have been strong contributors but for different reasons. Within Industrials, we saw European defence companies offering compelling valuations post the strong run up in cyclical stocks in the latter half of 2020 and early 2021. These stocks have done well on the back of markets that have shunned cyclical stocks. They’ve also benefitted from the Ukraine war causing European governments to recommit to their defence spending targets and even pull those forward.

Within Consumer Discretionary, it has been a mix where during the Covid-19 crisis cyclical stocks came under meaningful pressure. Further, our underweight to the Financials, Consumer Staples, and Industrials sectors, combined with an underweight to the Information Technology and Communication Services sectors, were further sources of positive relative returns.

Although we do not invest on a thematic basis, the portfolio is broadly tilted more towards defensive and compounding stocks versus cyclical stocks. Defensive stocks have held up well, but we are starting to see more cyclical opportunities.  The Fund is overweight the Consumer Staples, Industrials, and Materials sectors, with a large underweight to the Information Technology sector.

Q: You look to exploit market inefficiencies and find mispriced companies. Why do these discounts occur?

BK: Markets will tend to trade on short-term news and extrapolate that information into the future, whether positive or negative. For a patient long-term investor, this will always provide opportunities to exploit short-term inefficiencies. Our process takes us to areas of the markets where there are controversies, such as missed earnings, supply chain disruptions, changing macro environment, management missteps, etc. But if we can see a resolution to these controversies over the next three to five years, this allows us to buy companies that are trading at a meaningful discount to our estimate of intrinsic value.

Q: As a value investor and stock picker, to what extent do major macro themes play into your company investment decisions?

BK: Our investment process is macro aware but not macro driven. We are cognisant of broader macro indicators such as changes in currency rates, PMIs, unemployment rates, interest rates, etc., and will take these factors into account as part of our portfolio construction process and, just as importantly, as part of our bottom-up, fundamental company analysis. We regularly review our investment screens, which tend to act as indicators of dislocations in the market.

Q: Do you expect to hold some of the stocks in your portfolio for say 10 years?

BK: Where we see a company continuing to compound value greater than what the market is willing to account for, we will be long-term holders. We would expect this to occur more often in the more stable areas of the market such as the Utilities, Health Care, or Consumer Staples sectors. However, we sometimes see this in the more cyclical areas of the market such as Energy. If the company we own continues to compound its earnings power without a commensurate re-rating of the valuation by the market in recognizing that higher earnings power.

Q: In your analysis, you look for “downside protection if company fundamentals fail to improve.” Can you give examples of such protection?

BK: We spend as much time on what could go wrong with our investment as what could go right. This is instrumental in assessing not only the risk/reward potential of the company but also in establishing the weighting of the security in the portfolio. During the COVID crisis we undertook a full reassessment of every name in the portfolio to confirm that our downside estimates were reasonable and that the companies we owned could survive economic lockdowns. One company was closely tied to consumer spending but it had the cash on the balance sheet and length of cash burn before needing to tap the bond or equity markets. We were patient during this period in not selling or adding to the position until we could see improvement or deterioration. Company management was able to obtain favourable financing in the debt market without diluting existing shareholder equity. With a stronger balance sheet, we added to our position and and the stock meaningfully rerated higher.

Q: Have you sold a stock recently that did not work out as well as expected and taught you something about your investment process?

BK: We have recently sold a position where our original thesis centred on the company having undergone a series of divestitures and restructuring initiatives, leaving the company primarily focused on its healthcare business while completely exiting its consumer electronics businesses. We believe this transition was not fully appreciated by the market. However, the company is currently involved in a product recall of one of its healthcare devices and the risk of high recall costs and costly potential litigation have caused the stock price to meaningfully underperform. Accordingly, the investment thesis has transitioned from business fundamentals to product recall and litigation and is something we are no longer willing to bet on. Our experiences with these problems have taught us that the market can extend the duration and magnitude of these losses.

Q: How do you decide if a company has a quality management team when many CEOs are skilled presenters and talkers?

BK: The risk when talking with management is getting caught up in a good story or relying on promises when management cannot deliver. Investors cannot rely fully on company management plans, projections, etc, exclusively as part of the analysis. We do additional channel checking with either customers, suppliers, competitors, industry sources, and so one, and we have a long history in these industries or with these company management teams. It’s important to be objective in assessing results.

Q: What gives you confidence that the value market we have seen of late will not be short lived as we have seen over the last 10+ years?

BK: If you look back over the last 10+ years, there was little change in the overall economic backdrop, with low interest rates, low inflation and below-trend economic growth, all of which favoured growth stocks which are seen as long duration assets. This pushed the multiples of these growth companies to historic levels and caused indexes to become concentrated in just a few names – not that much different from the late 1990s.

However, the recent economic challenges with inflation mean central banks will need to lift interest rates to substantially higher levels than seen in decades. This puts meaningful pressure on growth stocks. Further, there will come a point at which economies will begin to recover, recognising they may experience more pain, and value stocks will do well going into that recovery. The set-up for value stocks appears good and we expect this value cycle will be longer in duration than what we have seen over the last several years, although we recognise that there will be pauses along the way.

 

Brad Kinkelaar is Senior Managing Director and Lead Portfolio Manager for the Barrow Hanley Global Share Fund. Barrow Hanley Global Investors was founded in 1979 in Dallas, USA, and is now part of Perpetual Asset Management International.

Perpetual Asset Management Australia is a sponsor of Firstlinks. This article contains general information only and is not intended to provide you with financial advice or take into account your objectives, financial situation or needs. Stock charts are provided by Morningstar. The product disclosure statement (PDS) for the Barrow Hanley Global Share Fund, issued by Perpetual Investment Management Limited (ABN 18 000 866 535 AFSL 234426) (Perpetual), should be considered before deciding whether to acquire or hold units in this fund. The PDS and Target Market Determination can be obtained by calling 1800 022 033 or visiting www.perpetual.com.au. Perpetual has appointed Barrow Hanley Global Investors as the investment manager of the Barrow Hanley Global Share Fund. Barrow Hanley Global Investors is an authorised representative (Representative number 001283250) of Perpetual Corporate Trust Limited (ABN 99 000 341 533, AFSL 392673) under its Australian Financial Services Licence.

For more articles and papers from Perpetual, please click here.

 

  •   5 October 2022
  • 1
  •      
  •   

RELATED ARTICLES

A different approach to equity income investing

The time for bonds has come

Does Barrenjoey hold the key to Magellan's fortunes?

banner

Most viewed in recent weeks

Noel Whittaker’s take on the budget

Marketed as a fix for inequality and housing affordability, the latest budget instead delivers a tangle of tax changes that leave everyday Australians worse off.

Australia has no death duties. Technically.

Australia may not levy formal death duties, but a growing web of tax measures is quietly shaping what wealth passes between generations. Now, the 2026 budget adds another layer.

How to minimise tax with a will

Inheritance tax implications in Australia may surprise some, as poor estate planning without proper wills or trusts can lead to costly tax bills and delays for beneficiaries.

Testamentary trusts post-budget: Estate planning, tax reform and the ‘death tax’ debate

Proposed Budget changes to taxation are casting new uncertainty over testamentary trusts, prompting closer scrutiny of estate planning structures and the real implications of reforms still taking shape.

Back to the future - Why indexing CGT is a good idea

A return to indexation of capital gains would be a fairer way to compensate households for the effects of inflation than the current discount. Importantly, it opens the door to future, broader reforms to stop the taxation of inflation.

The investment mistake killing your returns

Retail investors face an increasingly complex product environment, but simplicity may be the most overlooked advantage in building a portfolio you can actually live with.

Latest Updates

Investment strategies

Choose your hedges wisely… and often

A new market regime is exposing the fragility of static hedges. With correlations shifting and safe havens flipping, investors must rethink diversification and adopt more adaptive tools to protect capital.

Investment strategies

Yields take centre stage again

The Australian credit landscape is shifting. Yields are rising, issuance is strong and spreads continue to tighten. Income is re‑emerging as the dominant driver of returns, though pockets of risk may be building beneath the surface.

Investment strategies

The grass is always greener: Rethinking Australian vs global equities

Australia's once‑dominant sharemarket is losing ground as others surge ahead, prompting investors to question home‑bias instincts. Meanwhile, the US market appears attractive. Is it time to revisit your global equity allocation?

Investment strategies

Stop asking if there's a stock market bubble. Ask this instead.

Markets continue to push onwards despite valuations looking stretched by historical standards. Bubble talk is rampant, however investors may be focusing on the wrong thing. The real story sits deeper than the headlines.

Taxation

The GST cannot stop inflation

Raising the GST when inflation jumps sounds clever on paper, until we examine how it may play out in practice. What is pitched as a simple inflation fix can lead to a sharp turn in the wrong direction for prices.

Shares

Why SpaceX is coming to your super fund

SpaceX’s blockbuster debut is grabbing headlines, but the real story for Australian investors is much quieter. Giant listings eventually filter into super funds and ETFs, subtly reshaping portfolios long before most realise.

Taxation

Is the government being honest with us about its business CGT changes?

The government’s assurances on small‑business concessions don’t withstand the scrutiny. Token carve‑outs and a lack of credible rationale for CGT changes may reshape how Australia rewards long‑term value creation. 

Sponsors

Alliances

© 2026 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.